Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108546720B reveals a green lipase-catalyzed route for Indobufen intermediates, offering high optical purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN115536720A details a novel chemical synthesis for cholic acid intermediate A8, offering a virus-free, plant-based alternative to animal extraction with scalable manufacturing potential.
Patent CN118056823A reveals a scalable route for high-purity Platinib intermediates. This process eliminates chromatography, ensuring cost reduction and supply reliability for pharmaceutical manufacturers.
Novel hydrolysis route for 2-(trifluoromethyl)benzaldehyde offers high purity and industrial scalability for pharma intermediates.
Novel Acinetobacter strain enables high-concentration biocatalysis for chiral acid production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Advanced low-temperature selective hydrolysis method for cefuroxime acid production. High purity, reduced waste, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN102851238B reveals enzymatic hydrolysis breakthrough. Offers high purity and cost reduction in Pharmaceutical Intermediates manufacturing for global supply chains.
Patent CN1443182A reveals a mild base purification method reducing dimeric impurities in statins. Enhance supply chain reliability and cost reduction in pharmaceutical manufacturing.
Novel whole-cell method for L-menthol synthesis offers high ee and cost efficiency. Reliable supplier for flavor and fragrance intermediates with scalable green chemistry.
Patent CN1823074A details a chromatography-free route for bicyclic heteroaryl aldehydes. Discover cost-effective manufacturing and high-purity pharmaceutical intermediates.
Patent CN102180914A details a high-yield synthesis of 2-Deoxy-D-Glucose via selective addition. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN1756734A details a novel route for Monatin derivatives using 4-protected hydroxypyroglutamic acid. Offers high optical purity and simplified processing for industrial scale-up.
Patent CN107988307A details enzymatic resolution for high-purity intermediates. This method offers significant supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN101575286B details a novel route for simvastatin ammonium salt, offering higher purity and yield for API manufacturing supply chains.
Patent CN101190927A reveals a streamlined synthesis for Adefovir Monoester via selective hydrolysis, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN110759957B reveals a novel KOH-catalyzed route for lipid-soluble isoguanosine intermediates, enhancing bioavailability and reducing purification costs for antisense therapies.
Advanced preparation of Tenofovir Disoproxil degradation impurity via selective hydrolysis. Enhancing API quality control and supply chain stability for global pharma.
Patent CN101891797A reveals a selective hydrolysis method for steroidal 17α-esters, offering superior yield and purity for pharmaceutical manufacturing supply chains.
Novel hydrolysis method enhances purity and yield for pemetrexed disodium intermediate manufacturing, offering significant supply chain reliability and cost reduction benefits for global pharmaceutical partners.
Advanced stereocontrolled synthesis of trans-5-chloro-2-methyl-dibenzo-oxepino-pyrrole intermediates. Enhancing yield and purity for global pharmaceutical supply chains.